G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$3.72 USD
-0.27 (-6.77%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $3.72 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum C VGM
Earnings News For GTHX
-
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
-
Will G1 Therapeutics (GTHX) Report Negative Earnings Next Week? What You Should Know
-
G1 Therapeutics (GTHX) Tops Q2 Earnings and Revenue Estimates
-
G1 Therapeutics (GTHX) Reports Q1 Loss, Tops Revenue Estimates
-
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
-
G1 Therapeutics (GTHX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
G1 Therapeutics (GTHX) Reports Q3 Loss, Tops Revenue Estimates
-
G1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
-
Analysts Estimate G1 Therapeutics (GTHX) to Report a Decline in Earnings: What to Look Out for
-
G1 Therapeutics (GTHX) Reports Q1 Loss, Tops Revenue Estimates
-
Earnings Preview: G1 Therapeutics (GTHX) Q1 Earnings Expected to Decline
-
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
-
G1 Therapeutics (GTHX) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: G1 Therapeutics (GTHX) Q3 Earnings Expected to Decline
-
G1 THERAPEUTICS (GTHX) Reports Q2 Loss, Tops Revenue Estimates
-
Analysts Estimate G1 THERAPEUTICS (GTHX) to Report a Decline in Earnings: What to Look Out for
-
G1 THERAPEUTICS (GTHX) Reports Q1 Loss, Tops Revenue Estimates